Community Academic Profiles–

Lorrin Koran

Back to Profile

Publication Details

  • High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.

    Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, Robinson DG, Crits-Christoph P, Mandel FS, Austin C. J Clin Psychiatry. 2006; 67 (1): 15-22

    To evaluate the efficacy and safety of high-dose sertraline for patients with obsessive-compulsive disorder (OCD) who failed to respond to standard sertraline acute treatment.

    PubMedID: 16426083

Stanford Medicine Resources:

Footer Links: